secwatch.observer — SEC 8-K summary
======================================

Issuer:     Nutex Health Inc. (NUTX)
CIK:        0001479681
Form:       8-K
Filed at:   2024-08-08T23:59:59+00:00
Accession:  0001479681-24-000008
Event type: earnings
Sentiment:  positive
Materiality: 0.70
Item codes: 2.02, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Nutex Health Q2 revenue up 29% to $76.1M; Adjusted EBITDA up 200% to $12.0M
---------------------------------------------------------------------------

- Net loss attributable to Nutex of $0.4M vs $3.5M loss in Q2 2023; H1 net loss $0.7M vs $8.6M.
- Hospital division visits 41,208 in Q2 (+28% YoY); mature hospital revenue +13.2%.
- Adjusted EBITDA (attributable) $12.0M in Q2, up 200% YoY; H1 Adjusted EBITDA $16.6M (+159%).
- Operating cash flow of $16.3M in H1 2024; cash $40.8M, long-term debt $22.4M.
- Non-cash impairments of $3.5M assets and $3.2M goodwill; $3.1M gain on warrant liability.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1479681/000147968124000008/0001479681-24-000008-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1479681/000147968124000008/nutx-20240808x8k.htm
  HTML page:      https://secwatch.observer/filing/0001479681-24-000008

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer